(Q33916981)

30 July 2017

1 reference

title

Clinically significant pharmacokinetic interactions between dietary caffeine and medications (English)

1 reference

30 July 2017

1 reference

Carrillo JA

1

1 reference

30 July 2017

Benitez J

series ordinal

2

1 reference

30 July 2017

publication date

1 August 2000

1 reference

Clinical Pharmacokinetics

30 July 2017

published in

1 reference

30 July 2017

volume

39

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

127-153

1 reference

Accumulation of caffeine in healthy volunteers treated with furafylline

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers—N‐desisopropylation is mediated mainly by CYP1A2

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Metabolism of theophylline by cDNA-expressed human cytochromes P-450.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Decreased systemic clearance of caffeine due to cimetidine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Interaction between oral ciprofloxacin and caffeine in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Comparative effects of ciprofloxacin and lomefloxacin on the oxidative metabolism of theophylline

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Effect of allopurinol on caffeine disposition in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Anxiety and depression associated with caffeinism among psychiatric inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Caffeine and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Response to "Effects of caffeine on behavior of schizophrenic inpatients".

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Inhibitors of imipramine metabolism by human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Disposition of clozapine in man: lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Clozapine plasma levels and convulsions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

The influence of quinolone derivatives on theophylline clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Influence of lomefloxacin on the pharmacokinetics of theophylline

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Lack of interaction between lomefloxacin and caffeine in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Effect of lomefloxacin on theophylline pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Caffeine renal clearance and urine caffeine concentrations during steady state dosing. Implications for monitoring caffeine intake during sports events

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200039020-00004

Effect of ketoconazole and terbinafine on the pharmacokinetics of caffeine in healthy volunteers

21 January 2018

1 reference

12 December 2020

Effects of cimetidine on caffeine disposition in smokers and nonsmokers

1 reference

12 December 2020

Are adverse drug reactions attributed to fluvoxamine caused by concomitant intake of caffeine?

1 reference

12 December 2020

Olanzapine Serum Concentrations in Psychiatric Patients Given Standard Doses: The Influence of Comedication

1 reference

12 December 2020

Low-dose caffeine physical dependence in humans

1 reference

12 December 2020

Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine

1 reference

12 December 2020

Lack of effect of olanzapine on the pharmacokinetics of a single aminophylline dose in healthy men

1 reference

12 December 2020

Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's disease

1 reference

12 December 2020

Drug-drug interactions with fluoroquinolones.

1 reference

12 December 2020

Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin

1 reference

12 December 2020

Inhibition of theophylline metabolism by mexiletine in young male and female nonsmokers

1 reference

12 December 2020

Cimetidine-theophylline interaction: report of four patients

1 reference

12 December 2020

Fluvoxamine is a potent inhibitor of cytochrome P4501A2

1 reference

12 December 2020

Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1

1 reference

12 December 2020

Stereoselective disposition of the antiarrhythmic agent mexiletine during the concomitant administration of caffeine

1 reference

12 December 2020

Determination of urinary metabolites of caffeine for the assessment of cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activity in humans.

1 reference

12 December 2020

Comparative studies on interaction between theophylline and quinolones

1 reference

12 December 2020

Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine.

1 reference

12 December 2020

Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens

1 reference

12 December 2020

Physical dependence increases the relative reinforcing effects of caffeine versus placebo

1 reference

12 December 2020

4-quinolones inhibit biotransformation of caffeine

1 reference

12 December 2020

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole

1 reference

12 December 2020

The effect of fleroxacin and ciprofloxacin on the pharmacokinetics of multiple dose caffeine

1 reference

12 December 2020

Unsuspected caffeine toxicity complicating theophylline therapy

1 reference

12 December 2020

Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture

1 reference

12 December 2020

Differential effects of cimetidine on theophylline metabolic pathways

1 reference

12 December 2020

Methoxsalen is a potent inhibitor of the metabolism of caffeine in humans

1 reference

12 December 2020

Clinical significance of plasma levels of clomipramine, its hydroxylated and desmethylated metabolites: prediction of clinical outcome in mood disorders using discriminant analysis of therapeutic drug monitoring data

1 reference

12 December 2020

Therapeutic drug monitoring of clozapine treatment. Therapeutic threshold value for serum clozapine concentrations

1 reference

12 December 2020

Clinical pharmacology of caffeine

1 reference

12 December 2020

Plasma level monitoring of antipsychotic drugs. Clinical utility

1 reference

12 December 2020

Heterocyclic amines, cytochrome P4501A2, and N-acetyltransferase: issues involved in incorporating putative genetic susceptibility markers into epidemiological studies

1 reference

12 December 2020

Will routine therapeutic drug monitoring have a place in clozapine therapy?

1 reference

12 December 2020

Overview of drug interactions with the quinolones

1 reference

12 December 2020

Cytochrome P450 IA2 activity in man measured by caffeine metabolism: effect of smoking, broccoli and exercise

1 reference

12 December 2020

Variability in caffeine metabolism

1 reference

12 December 2020

Caffeine and the elderly

1 reference

12 December 2020

Central nervous system toxicity of quinolones: human and animal findings

1 reference

12 December 2020

Effect of quinolones on caffeine disposition

1 reference

12 December 2020

Caffeine and sport: role of physical exercise upon elimination.

1 reference

12 December 2020

Effects of Temafloxacin and Ciprofloxacin on the Pharmacokinetics of Caffeine†

1 reference

12 December 2020

[Effect of caffeine on xanthine oxidase activity]

1 reference

12 December 2020

Quinolone inhibition of cytochrome P-450-dependent caffeine metabolism in human liver microsomes

1 reference

12 December 2020

Influence of caffeine on aspirin pharmacokinetics

1 reference

12 December 2020

Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2

1 reference

12 December 2020

Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities

1 reference

12 December 2020

Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450.

1 reference

12 December 2020

Assessment of caffeine exposure: caffeine content of beverages, caffeine intake, and plasma concentrations of methylxanthines

1 reference

12 December 2020

Inactivation of human liver cytochrome P-450 by the drug methoxsalen and other psoralen derivatives

1 reference

12 December 2020

Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N -acetyltransferase 2 and CYP1A2 activities

1 reference

12 December 2020

Intraindividual and interindividual variability in the disposition of the local anesthetic ropivacaine in healthy subjects.

1 reference

12 December 2020

Pharmacoepidemiology of the effect of caffeine on blood pressure

1 reference

12 December 2020

Increased anxiogenic effects of caffeine in panic disorders

1 reference

12 December 2020

The effect of liver disease on urine caffeine metabolite ratios

1 reference

12 December 2020

Identification of human cytochrome P450 isoforms involved in the stereoselective metabolism of mianserin enantiomers

1 reference

12 December 2020

Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes

1 reference

12 December 2020

Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.

1 reference

12 December 2020

Are we dependent upon coffee and caffeine? A review on human and animal data

1 reference

12 December 2020

Elevated levels of clozapine in serum after addition of fluvoxamine

1 reference

12 December 2020

Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism

1 reference

12 December 2020

Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence

1 reference

12 December 2020

Fluvoxamine. A review of global drug-drug interaction data

1 reference

12 December 2020

Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid

1 reference

12 December 2020

Influence of ethinylestradiol-containing combination oral contraceptives with gestodene or levonorgestrel on caffeine elimination

1 reference

12 December 2020

Tolerance to the humoral and hemodynamic effects of caffeine in man.

1 reference

12 December 2020

CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeine

1 reference

12 December 2020

Relationship between fluvoxamine pharmacokinetics and CYP2D6/CYP2C19 phenotype polymorphisms

1 reference

12 December 2020

Ondansetron Clinical Pharmacokinetics

1 reference

12 December 2020

Clinical significance of pharmacokinetic drug interactions with over-the-counter (OTC) drugs

1 reference

12 December 2020

Renal lithium excretion in man

1 reference

12 December 2020

Ofloxacin clinical pharmacokinetics

1 reference

12 December 2020

Theophylline-mexiletine interaction: a case report

1 reference

12 December 2020

Characterisation of theophylline metabolism by human liver microsomes. Inhibition and immunochemical studies

1 reference

12 December 2020

Differences in interactions of SSRIs

1 reference

12 December 2020

The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine

1 reference

12 December 2020

Inhibition of caffeine metabolism by 5-methoxypsoralen in patients with psoriasis

1 reference

12 December 2020

The effect of caffeine on the pharmacokinetics of acetaminophen in man

1 reference

12 December 2020

Analysis of urinary caffeine metabolites to assess biotransformation enzyme activities by reversed-phase high-performance liquid chromatography.

1 reference

12 December 2020

Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva.

1 reference

12 December 2020

Comments to "interaction between caffeine and clozapine"

1 reference

12 December 2020

Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae

1 reference

12 December 2020

Omeprazole and lansoprazole are not inducers of cytochrome P4501A2 under conventional therapeutic conditions

1 reference

12 December 2020

Verapamil and drug metabolism by the cytochrome P450 isoform CYP1A2

1 reference

12 December 2020

Inhibition and induction of theophylline metabolism by 8-methoxypsoralen. In vivo study in rats and humans.

1 reference

12 December 2020

Caffeine poisoning in infants resulting from confusion between dosage forms. Apropos of 5 cases

1 reference

12 December 2020

Fluvoxamine Inhibition and Carbamazepine Induction of the Metabolism of Clozapine

1 reference

12 December 2020

Clinical pharmacokinetics of antidepressants in the elderly. Therapeutic implications

1 reference

12 December 2020

A population and family study of CYP1A2 using caffeine urinary metabolites

1 reference

12 December 2020

Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy.

1 reference

12 December 2020

Caffeine self-administration and withdrawal: incidence, individual differences and interrelationships

1 reference

12 December 2020

Human cytochromes P4501A1 and P4501A2: R-warfarin metabolism as a probe

1 reference

12 December 2020

Are antipsychotic drugs potentially chemopreventive agents for cancer?

1 reference

12 December 2020

Inhibition by idrocilamide of the disposition of caffeine

1 reference

12 December 2020

Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.

1 reference

12 December 2020

Methylxanthines: toxicity to humans. 2. Caffeine

1 reference

12 December 2020

Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes

1 reference

12 December 2020

5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis

1 reference

12 December 2020

Clinical Pharmacokinetics of Lansoprazole

1 reference

12 December 2020

Manic psychosis after coffee and phenylpropanolamine

1 reference

12 December 2020

Analysis of midazolam and metabolites in plasma by high-performance liquid chromatography: probe of CYP3A.

1 reference

12 December 2020

Theophylline and warfarin interaction studies with grepafloxacin

1 reference

12 December 2020

Interaction between caffeine and clozapine

1 reference

12 December 2020

Effects of caffeine with repeated dosing

1 reference

12 December 2020

Severe hypertension after ingestion of an appetite suppressant (phenylpropanolamine) with indomethacin

1 reference

12 December 2020

Pan-fried meat containing high levels of heterocyclic aromatic amines but low levels of polycyclic aromatic hydrocarbons induces cytochrome P4501A2 activity in humans

1 reference

12 December 2020

Relationship between caffeine concentrations in plasma and saliva

1 reference

12 December 2020

Precipitation of antipsychotic drugs in interaction with coffee or tea

1 reference

12 December 2020

Pefloxacin clinical pharmacokinetics

1 reference

12 December 2020

Determination of carcinogenic arylamine N-oxidation phenotype in humans by analysis of caffeine urinary metabolites

1 reference

12 December 2020

Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines

1 reference

12 December 2020

Lidocaine metabolism by human cytochrome P-450s purified from hepatic microsomes: comparison of those with rat hepatic cytochrome P-450s.

1 reference

12 December 2020

The drug methoxsalen, a suicide substrate for cytochrome P-450, decreases the metabolic activation, and prevents the hepatotoxicity, of carbon tetrachloride in mice

1 reference

12 December 2020

Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses

1 reference

12 December 2020

The influence of caffeine on the steady-state pharmacokinetics of theophylline.

1 reference

12 December 2020

Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole

1 reference

12 December 2020

An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro. Studies with human and rat liver microsomes

1 reference

12 December 2020

Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites

1 reference

12 December 2020

Bioequivalence evaluation of two flutamide preparations in healthy female subjects

1 reference

12 December 2020

Seizures following smoking cessation in a clozapine responder

1 reference

12 December 2020

In vivo inhibition of CYP2C19 but not CYP2D6 by fluvoxamine

1 reference

12 December 2020

Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test.

1 reference

12 December 2020

P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR.

1 reference

12 December 2020

Caffeine withdrawal: a parametric analysis of caffeine dosing conditions

1 reference

12 December 2020

Activation of carcinogens by human liver cytochromes P-450.

1 reference

12 December 2020

Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes.

1 reference

12 December 2020

Impaired elimination of caffeine by oral contraceptive steroids

1 reference

12 December 2020

The effects of quinolones on xanthine pharmacokinetics

1 reference

12 December 2020

The relationship between serum concentration and therapeutic effect of haloperidol in patients with acute schizophrenia

1 reference

12 December 2020

Interaction of Phenothiazine and Related Drugs and Caffeinated Beverages

1 reference

12 December 2020

Regulation of dioxin receptor function by omeprazole

1 reference

12 December 2020

Pharmacokinetic optimisation of therapy with newer antidepressants

1 reference

12 December 2020

Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans

1 reference

12 December 2020

Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: coincidence with plasma clearance and breath test

1 reference

12 December 2020

Lack of inhibitory effect of cimetidine on caffeine metabolism in children using the caffeine breath test

1 reference

12 December 2020

Fluoroquinolone toxicity profiles: a review focusing on newer agents

1 reference

12 December 2020

Lack of influence of pantoprazole on the disposition kinetics of theophylline in man.

1 reference

12 December 2020

Convulsions related to enoxacin

1 reference

12 December 2020

Menstrual cycle effects on caffeine elimination in the human female

1 reference

12 December 2020

Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase

1 reference

12 December 2020

Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.

1 reference

12 December 2020

Psoralens and related compounds in the treatment of psoriasis

1 reference

12 December 2020

Inhibition and induction of cytochrome P450 and the clinical implications

1 reference

12 December 2020

Four-week treatment with omeprazole increases the metabolism of caffeine

1 reference

12 December 2020

The biotransformation of clomipramine in vitro, identification of the cytochrome P450s responsible for the separate metabolic pathways

1 reference

12 December 2020

Impact of long-term ethanol consumption on CYP1A2 activity

1 reference

12 December 2020

Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine

1 reference

12 December 2020

The effect of multiple doses of phenylpropanolamine on the blood pressure of patients whose hypertension was controlled with beta blockers

1 reference

12 December 2020

Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity

1 reference

12 December 2020

Lack of drug interaction between omeprazole, lansoprazole, pantoprazole and theophylline

1 reference

12 December 2020

Cimetidine-theophylline interaction in patients with chronic obstructive airways disease

1 reference

12 December 2020

Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine

1 reference

12 December 2020

Phenylpropanolamine increases plasma caffeine levels.

1 reference

12 December 2020

Major pathway of imipramine metabolism is catalyzed by cytochromes P-450 1A2 and P-450 3A4 in human liver

1 reference

12 December 2020

Clozapine levels and caffeine

1 reference

12 December 2020

Antiarrhythmic prophylaxis after acute myocardial infarction. Is lidocaine still useful?

1 reference

12 December 2020

Olanzapine plasma concentrations and clinical response in acutely ill schizophrenic patients

1 reference

12 December 2020

Involvement of CYP1A2 in mexiletine metabolism

1 reference

12 December 2020

Clinical pharmacokinetics of mexiletine

1 reference

12 December 2020

Metabolic activation of carcinogens

1 reference

12 December 2020

Omeprazole does not enhance the metabolism of phenacetin, a marker of CYP1A2 activity, in healthy volunteers

1 reference

12 December 2020

Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action

1 reference

12 December 2020

Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities

1 reference

12 December 2020

Caffeine metabolism in a healthy Spanish population: N-acetylator phenotype and oxidation pathways

1 reference

12 December 2020

Effect of single doses of rufloxacin on the disposition of theophylline and caffeine after single administration

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic modeling of caffeine: tolerance to pressor effects

1 reference

12 December 2020

Caffeine: a new look at an age-old drug.

1 reference

12 December 2020

Interspecies comparison of in vivo caffeine pharmacokinetics in man, monkey, rabbit, rat, and mouse

1 reference

12 December 2020

The use of caffeine for enzyme assays: a critical appraisal

1 reference

12 December 2020

Changes in rate and pattern of caffeine metabolism after cigarette abstinence

1 reference

12 December 2020

Measurement of coffee and caffeine intake: Implications for epidemiologic research

1 reference

12 December 2020

Theophylline steady state pharmacokinetics is not altered by omeprazole

1 reference

12 December 2020

Oral contraceptive steroids impair the elimination of theophylline

1 reference

12 December 2020

Role of well-done, grilled red meat, heterocyclic amines (HCAs) in the etiology of human cancer

1 reference

12 December 2020

Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition

1 reference

12 December 2020

Genetically variable metabolism of antidepressants and neuroleptic drugs in man.

1 reference

12 December 2020

Identification of P450 enzymes involved in metabolism of verapamil in humans

1 reference

12 December 2020

Effect of trovafloxacin, a new fluoroquinolone antibiotic, on the steady-state pharmacokinetics of theophylline in healthy volunteers

1 reference

12 December 2020

Plasma tacrine concentrations are significantly increased by concomitant hormone replacement therapy

1 reference

12 December 2020

The disposition of caffeine during and after pregnancy

1 reference

12 December 2020

Inactivation of cytochrome P-450 by the drug methoxsalen

1 reference

12 December 2020

A simple test for acetylator phenotype using caffeine

1 reference

12 December 2020

Quantitative assessment of caffeine partial clearances in man.

1 reference

12 December 2020

Inhibition of caffeine metabolism by estrogen replacement therapy in postmenopausal women

1 reference

12 December 2020

Tumor-specific expression of cytochrome P450 CYP1B1.

1 reference

12 December 2020

Seventh International Caffeine Workshop, Santorini, Greece 13-17 June 1993.

1 reference

12 December 2020

Effects of caffeine in chronic psychiatric patients

1 reference

12 December 2020

Pharmacological rationale for the clinical use of caffeine

1 reference

12 December 2020

Inhibition and induction of human cytochrome P450 (CYP) enzymes

1 reference

12 December 2020

In vitro interaction of the antipsychotic agent olanzapine with human cytochromes P450 CYP2C9, CYP2C19, CYP2D6 and CYP3A

1 reference

12 December 2020

Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives

1 reference

12 December 2020

Supraventricular tachycardia in a patient receiving ECT, clozapine, and caffeine

1 reference

12 December 2020

Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients

1 reference

12 December 2020

Molecular genetics of the human cytochrome P450 monooxygenase superfamily

1 reference

12 December 2020

Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics

1 reference

12 December 2020

Variability of caffeine metabolism in humans

1 reference

12 December 2020

Lithium tremor and caffeine intake: two cases of drinking less and shaking more

1 reference

12 December 2020

Metabolism of the antiandrogenic drug (Flutamide) by human CYP1A2.

1 reference

12 December 2020

Gender effects in pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smoking

1 reference

12 December 2020

Verapamil-induced inhibition of theophylline elimination in healthy humans

1 reference

12 December 2020

Clinical Pharmacokinetics of Tacrine

1 reference

12 December 2020

Comparison of caffeine metabolism in three nonsmoking populations after oral administration of radiolabeled caffeine

1 reference

12 December 2020

Effect of caffeine on the bioavailability and pharmacokinetics of aspirin

1 reference

12 December 2020

Pharmacokinetic Interaction of Fluvoxamine and Thioridazine in Schizophrenic Patients

1 reference

12 December 2020

Possible psychiatric significance of excessive coffee consumption

1 reference

12 December 2020

Caffeine and cardiac arrhythmias

1 reference

12 December 2020

Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: dominance of CYP 2C19 and 3A4

1 reference

12 December 2020

Lower plasma levels of haloperidol in smoking than in nonsmoking schizophrenic patients

1 reference

12 December 2020

Steady-state levels of imipramine and its metabolites: significance of dose-dependent kinetics

1 reference

12 December 2020

Influence of usual intake of dietary caffeine on single-dose kinetics of theophylline in healthy human subjects

1 reference

12 December 2020

Decrease of caffeine elimination in man during co-administration of 4-quinolones

1 reference

12 December 2020

Sympathomimetic effects of paraxanthine and caffeine in humans

1 reference

12 December 2020

Diltiazem treatment impairs theophylline elimination in patients with bronchospastic airway disease

1 reference

12 December 2020

The effect of three different oral doses of verapamil on the disposition of theophylline

1 reference

12 December 2020

1 reference

12 December 2020

Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias

1 reference

12 December 2020

The aryl hydrocarbon receptor complex

1 reference

12 December 2020

Inhibitory effects of antiarrhythmic drugs on phenacetin O-deethylation catalysed by human CYP1A2.

1 reference

12 December 2020

Influence of mexiletine on caffeine elimination

1 reference

12 December 2020

Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: inverse associations with plasma lutein and alpha-tocopherol.

1 reference

12 December 2020

A fluvoxamine-caffeine interaction study

1 reference

12 December 2020

Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics

1 reference

12 December 2020

Disposition and biotransformation of the antipsychotic agent olanzapine in humans

1 reference

12 December 2020

Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors

1 reference

12 December 2020

Famotidine and theophylline pharmacokinetics. An unexpected cimetidine-like interaction in patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2

1 reference

12 December 2020

Caffeine poisoning in a 19-year-old female

1 reference

12 December 2020

Saliva as a valid alternative to serum in monitoring intravenous caffeine treatment for apnea of prematurity.

1 reference

12 December 2020

Interaction between quinolones and caffeine

1 reference

12 December 2020

Five cases of fatal overdose from caffeine-containing "look-alike" drugs

1 reference

12 December 2020

Caffeine withdrawal increases lithium blood levels.

1 reference

12 December 2020

Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors

1 reference

12 December 2020

10.2165/00003088-200039020-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1024854490

0 references

1 reference